BURLINGTON, Mass., April  14, 2026  (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close.

LMAT

LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026

LeMaitre Vascular to Release Q1 2026 Earnings on May 5

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>BURLINGTON, Mass., April  14, 2026  (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close.</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>LeMaitre Vascular will report its first-quarter financial results on May 5, 2026, followed by a conference call discussing the company&#039;s outlook. Given their role in addressing a significant global health issue, future announcements could influence investor sentiment and stock performance.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>LeMaitre will announce Q1 2026 results on May 5.</li><li>Conference call scheduled for the same day to discuss outlook.</li><li>Company develops devices for peripheral vascular disease.</li><li>Peripheral vascular disease affects over 200 million worldwide.</li><li>Investors should prepare for a potential impact on stock.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>LeMaitre Vascular, Inc. (LMAT)</strong>: Primary focus of the article with upcoming earnings announcement.</li></ul>
  </section>

  <section data-block="category">
    <h3>Earnings</h3>
    <p>This fits under &#039;Earnings&#039; as it directly pertains to LeMaitre&#039;s financial results, essential for assessing future performance and investor decisions.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Q1 2026 financial results could affect investor sentiment significantly.</li><li>Positive or negative guidance may lead to stock price volatility.</li><li>Market reaction to earnings call could drive short-term trading activity.</li><li>Performance related to peripheral vascular disease market trends may impact LMAT.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Earnings release on May 5, 2026, after market close.</li><li>Conference call scheduled at 5 PM EDT the same day.</li><li>LeMaitre provides devices for peripheral vascular disease.</li><li>Peripheral vascular disease impacts over 200 million globally.</li><li>Company founded to support vascular surgeons&#039; needs.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Consider buying LMAT ahead of earnings for potential upside.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>BURLINGTON, Mass., April  14, 2026  (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/LMAT">LMAT</a>) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.</p>  <p>Access to the live call is available by registering online <a href="https://www.globenewswire.com/Tracker?data=iZSEi41Tm45MtqvdEKTqpG_N-j7bLGnUKRRwmnfEiAHfLn8iRYR3XeKO-9nyiR7Lq9sCWCmZsfC0Kosocau_B0z3K85T3Htkb_4TWs7xtpmYziKQ2FjTf1Jw7qbZwtIJecuoKkK-lt-H7AMidkf_dwa5R03s2UEl_tERFDc6kK0=" rel="nofollow" target="_blank">here</a>. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at <a href="https://www.globenewswire.com/Tracker?data=xlTtKFFBL4pVQoJhEqwj89Y_gn--PemxYcX3_OGFndQYufTgO8zfJip5RxOigXNaLYvpTHlcd0_gXo8Zxy0t5L5u7gjbNRtheSnkckWfBAM=" rel="nofollow" target="_blank">ir.lemaitre.com</a>.</p>  <p><strong>About LeMaitre</strong></p>  <p>LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at <a href="http://www.lemaitre.com" title="www.lemaitre.com">www.lemaitre.com</a>.</p>  <p>LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY4OTg5NiM3NTM1OTU4IzIwMDY3MDc="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/MDQxZmU2ZWEtMDFmNi00MDBjLWE2MDYtMWJhYmQ4NDg2ZjgwLTEwMTgyODAtMjAyNi0wNC0xNC1lbg==/tiny/LeMaitre-Vascular-Inc-.png" referrerpolicy="no-referrer-when-downgrade"></img><pre>Contact: 
Gregory Manker
Director, Business Development &amp; Investor Relations
LeMaitre Vascular, Inc.
+1 781-362-1260 
<a href="mailto:gmanker@lemaitre.com">gmanker@lemaitre.com</a>
</pre><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/8b8755b7-6f04-4650-9c94-0a2d0654fd49"><img src="https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg" border="0" width="150" height="53" alt="Primary Logo"></img></a></p>

LeMaitre Vascular will report its first-quarter financial results on May 5, 2026, followed by a conference call discussing the company's outlook. Given their role in addressing a significant global health issue, future announcements could influence investor sentiment and stock performance.

LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Earnings

Related News